"Our collaboration with Eshe emerged from a shared mission to empower women through health, well-being, and quality care," Dr. Marianna Prokopi–Demetriades, Co-founder of RSL Revolutionary Labs Ltd. says, elaborating on the recent company's collaboration with the digital platform towards bringing its εὖSKIN® products to a new audience in Sub-Saharan Africa.
Noting that εὖSKIN® was developed to address the often-overlooked needs of oncology patients, particularly women coping with the side effects of cancer therapies such as skin damage, dryness, and sensitivity, Prokopi–Demetriades told CBN that, "When we discovered Eshe’s model--a digital platform that combines an AI companion, health tracking tools, community, knowledge hub, wellness content, and curated beauty & skincare products--we realised it was an ideal partner. Eshe isn’t just a marketplace; it is a women’s health ecosystem."
Also, as explained by the Cyprus-based scientist, "Africa was chosen as the first region for expansion through a digital, community-driven model, in contrast to our European launches, which followed more traditional market-entry approaches. With Eshe’s strong roots in Kenya, Nigeria, and South Africa, and their ability to connect directly with millions of women, this partnership allows us to introduce εὖSKIN® in a way that is both scalable and impactful."
"This partnership," she went on to underline, "combines RSL’s dermaceutical innovation with Eshe’s broad reach, trusted knowledge resources, and ability to connect personally with women through the app. Eshe brings the platform, the community, the voice and importantly, the medical professionals and expert collaborations that give women trusted guidance. We bring the science, product quality, and clinical grounding. Together, we create a model that is both impactful and sustainable."
With εὖSKIN® developed to address the previously mentioned frequently neglected needs of oncology patients, Prokopi-Demetriades pointed out that, "In Africa, where supportive care options are limited, εὖSKIN® offers not just skincare but relief, dignity, and comfort."
She also pointed out that, "Beyond oncology, the products also respond to the growing demand for natural, effective, science-led skincare solutions."
"By blending more than 15 natural ingredients with advanced biomaterials such as atelocollagen and hyaluronic acid, εὖSKIN® supports women in maintaining healthy skin, building resilience, and regaining confidence in their daily lives. In this way, the partnership has the potential to improve the quality of life for women both undergoing treatment and in their everyday wellness journeys," Prokopi-Demetriades explained.
"This expansion into Africa is a milestone for RSL Revolutionary Labs," the Co-founder continued, "It demonstrates that innovation created in Cyprus can extend its impact across continents."
"For the company, it means growing beyond European markets and pioneering a new digital-first entry model with Eshe."For patients," Prokopi-Demetriades went on to underline, "it means access to supportive care that was previously out of reach. And for us personally, it is the fulfillment of our mission: to improve quality of life for oncology patients everywhere, while also creating meaningful impact for women and communities across the globe. Through Eshe’s platform, this move also means engaging with a community that is actively seeking support and creating a safe space for knowledge exchange, where science, care, and lived experience come together."
Also read: Cypriot biotech company RSL Labs partners with Eshe to expand across Africa
Also read: RSL Revolutionary Labs and Europa Donna Cyprus join forces to support breast cancer patients
Also read: Dr. Marianna Prokopi-Demetriades wins Falling Walls Foundation Women’s Impact Award
Also read: RSL Revolutionary Labs partners with Aroma Hub to bring oncology skincare solutions to Malta
